In the present study, the e4ects of intrastriatal administration of di4erent concentrations (40 M, 400 M, and 4 mM) of inorganic mercury (HgCl 2 ) on the dopaminergic system of rat striatum were evaluated, using a microdialysis technique coupled to liquid chromatography-electrochemical detection. In previous studies, we discussed the e4ects of organic mercury (MeHg) administration on the striatal dopaminergic system on the basis of changes in the release and metabolism of striatal dopamine (DA). In the present study it is demonstrated that intrastriatal administration of all concentrations of HgCl 2 produced signi5-cant increases in the output of DA (1240, 2500, and 2658% for the concentrations of 40 M, 400 M, and 4 mM HgCl 2 , respectively) from rat striatal tissue, associated with signi5cant decreases in striatal levels of its metabolites dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) with the concentrations of 400 M and 4 mM HgCl 2 (74.4 and 3.4% for DOPAC and 71.0 and 50.6% for HVA, respectively), whereas no changes in metabolite levels were observed with the concentration of 40 M HgCl 2 . These e4ects are explained as a result of stimulated DA release and/or changed DA metabolism. The e4ects of intrastriatal administration of HgCl 2 were compared with those of MeHg on DA extracellular levels.
INTRODUCTION
Mercurials are environmental pollutants with a known neurotoxic action. The toxic e!ects of mercurials are dependent on chemical form, dose used, duration of exposure, and pathway of administration. However, intoxication with elemental mercury vapor or with metylmercury (MeHg) results in the accumulation of mercuric mercury (Hg>) in the brain (Brookes, 1992) . In both inorganic and organic forms, mercury is a potent neurotoxic agent upon chronic and acute exposure, expressing these toxic manifestations to di!erent degrees because of their di!erent lypophilities.
The inorganic forms of mercury (HgCl, HgCl ) are neurotoxic to di!erent degrees. The main target organ of mercuric chloride (HgCl ) is the kidney, where it is concentrated, producing renal damage and leading to death from uremia (Barnes et al., 1980) . While the kidney is generally considered the critical target organ, neurological disturbances have also been found after HgCl treatment, which in some cases resemble the e!ects of MeHg (Sirois and Atchison, 1996) . HgCl exerts a well-known inhibitory e!ect on membrane transport that is generally attributed to its high-a$nity interaction with protein sulfydryl groups (Bondy et al., 1979) . For example, submicromolar concentrations of HgCl have been found to inhibit selectively glutamate uptake in mouse astrocytes (Brookes, 1988; Brookes and Kristt, 1989) . Freitas et al. (1996) reported that both organic mercury and inorganic mercury inhibit Ca>-ATPase and Ca> uptake by brain microsomes with the inhibitory potency of inorganic mercury being higher than that of organic mercury, probably re#ecting di!erences in the a$nity for the sulfydryl groups of the mercury compounds.
Furthermore, the similarity in size and charge of various mercurials, particularly HgCl , to those of physiological ions such as Na> and Ca> suggests that they may enter the cell via ion channels (Miyamoto, 1983) .
Although mercuric salts penetrate the brain poorly (Brookes, 1992) , the direct intrastriatal administration of HgCl avoids the impairment of access into brain striatal tissue.
Because HgCl seems to be a neurotoxin with a possible in#uence on neurotransmission, it was decided to study its e!ects on the in vivo release of dopamine (DA), the main striatal neurotransmitter, and its main metabolites, dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), from rat striatum using a microdialysis technique coupled to high-performance liquid chromatography (HPLC) with electrochemical detection. Moreover, the e!ects of intrastriatal administration of HgCl were compared with those of MeHg on striatal DA in order to determine their possible mechanisms of action.
MATERIALS AND METHODS
Female adult Sprague}Dawley rats (weighing 240}260 g) were used in the experiments. Animals were housed under controlled conditions of temperature (22$23C) and photoperiod (light : dark 14 : 10 h), with free access to food and water. All experiments were performed in accordance with the Guidelines of the European Union Council (86/609/EU) and the Spanish Regulations (BOE 67/8509-12, 1988) for the Use of Laboratory Animals.
The HgCl (99%) was purchased from Sigma (St. Louis, MO) and was dissolved in the perfusion #uid and applied locally in the striatum via the dialysis probe. All other chemicals were analytical grade.
For microdialysis sampling, animals were anesthetized ip with chloral hydrate (400 mg/kg) and placed in a stereotaxic apparatus (Narishige SR-6) for the implantation of a guide cannula. A microdialysis probe (CMA/12, 3-mm membrane length) was implanted through the guide cannula into the left striatum at the following coordinates from Bregma: A/P#2.0 mm; L#3.0 mm; V#6.0 mm. After the experiments, rats were given an overdose of chloral hydrate, and brains were "xed with 10% formalin via intracardiac perfusion. Coronal sections (30 m) were made, stained with cresyl violet, and examined to determine the exact location of the dialysis probe.
Continuous perfusion was performed with a Ringer's solution (147 mM NaCl, 4 mM KCl, 3.4 mM CaCl ; pH 7.4) using a CMA/102 infusion pump (CMA/Microdialysis) at a #ow rate set at 2 l/min. The experiments were performed over 4 h with awake, conscious, and freely moving animals, with sampling of the striatal dialysates every 15 min (30 l).
The initial experiments were carried out 24 h after surgery, using di!erent concentrations of HgCl (40 M, 400 M, and 4 mM) dissolved in Ringer's solution and applied locally in the striatum via the dialysis probe. After four basal perfusates (60 min), for obtaining a stable output for DA and metabolites, the striatum was perfused with the di!erent concentrations of HgCl used for 60 min. Then, the perfusate was switched back to the unmodi"ed perfusion medium and the measurements continued for an additional period of 120 min.
In another set of experiments, the e!ects of HgCl administration on DA, DOPAC, and HVA extracellular levels were veri"ed using a second infusion of 400 M HgCl and a third infusion of 4 mM HgCl to the same animals that previously received 40 M HgCl , 1 and 2 weeks after "rst infusion, respectively. In this case, the dialysis probe was lowered via a chronically implanted guide cannula prior to each experiment using the same experimental conditions as those described above.
The samples obtained from the microdialysis procedure (30 l) were collected by means of a CMA/142 microsampler (CMA/Microdialysis), and DA, DOPAC, and HVA levels were quantitated by HPLC with electrochemical detection. The samples obtained from the microdialysis procedure were injected into a Hewlett-Packard Series 1050 Liquid Chromatograph, using a Rheodyne 7125 injection valve. The isocratic separation of DA, DOPAC, and HVA was carried out using Spherisorb ODS-1 reversed-phase columns (10-m particle size) according to DuraH n et al. (1998) . The eluent (pH 4.0) was prepared as follows: 70 mM KH PO , 1 mM octanesulfonic acid, 1 mM EDTA, and 5% methanol. The #ow rate was 1 ml/min. The detection of the substances was achieved by means of an ESA Coulochem 5100A electrochemical detector (Massachusetts) at a potential of #400 mV. The chromatograms obtained allowed the determination of DA, DOPAC, and HVA with a run time of 15 min.
The data were corrected for percentage of recovery for every microdialysis probe, which was similar for the di!erent probes and substances analyzed (17% for DA, 24% for DOPAC, and 24% for HVA). The averages of substance concentrations in the three samples before HgCl administration were considered as basal levels. These basal levels were considered as 100% in order to compare the di!erent responses of DA and metabolites after HgCl administration. The results are exhibited as the means$SEM of four to "ve experiments, expressed as percentage of basal levels.
Statistical analysis of the results was performed by means of repeated-measures ANOVA and the Student}New-man}Keuls multiple-range test, considering di!erences to be statistically signi"cant at the following levels: *P(0.05, **P(0.01, and ***P(0.001. Figure 1 presents the basal levels of DA, DOPAC, and HVA the day after surgery (considered as control) and 1 week and 2 weeks later. The basal output of dialysate DA and its metabolites from the striatum (means$SEM) before any infusion of HgCl (on day 1 after cannula implantation) was as follows: DA"0.15$0.01 (ng/15 min), DOPAC"16.60$ 0.49 (ng/15 min), and HVA"10.95$1.13 (ng/15 min). Basal values of DOPAC did not change 1 week later, whereas HVA basal levels increased in the same period (144% of basal levels on day 1). For both DOPAC and HVA, there was a decrease 2 weeks later (39.8 and 51.3%, respectively), related to their basal levels on day 1. In contrast, there were no changes in the basal concentrations of DA 1 and 2 weeks later.
RESULTS
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FIG. 1.
Basal values for DA, DOPAC, and HVA 1 day after cannula implantation, and 1 and 2 weeks later. The results are presented as means$SEM of four or "ve experiments, expressed as a percentage of basal levels (100%). Signi"cant di!erences: *P(0.05 and **P(0.01 with respect to basal level on day 1.
FIG. 2. E!ects of intrastriatal perfusion of di!erent concentrations of HgCl
(40 M, 400 M, and 4 mM) on DA (A), DOPAC (B), and HVA (C) extracellular levels from rat striatum. Arrow denotes the infusion of HgCl over 60 min. The results are presented as means$SEM of four or "ve experiments, expressed as a percentage of the basal levels (100%). Basal levels were considered as the mean of substance concentrations in the three samples before HgCl perfusion. Signi"cant di!erences: *P(0.05, **P(0.01, and ***P(0.001 with respect to basal levels.
output of DA ( Fig. 2A) . The individual experiments carried out on day 1 reveal that 40 M, 400 M, and 4 mM HgCl produced a maximum increase 75 min after the beginning of HgCl perfusion (1240$66%, 2500$424%, and 2658$337% of basal levels, respectively). Basal values recovered 120 min after administration of HgCl . The highest concentrations of HgCl assessed (400 M and 4 mM) caused a signi"cant decrease in extracellular levels of DOPAC and HVA in striatum 75 min after the beginning of HgCl administration (25.6 and 29% decrease for the 400 M concentration and 96.6 and 49.4% decrease for the 4 mM concentration with respect to basal levels, respectively) (Figs. 2B and 2C) . The smallest concentration of HgCl (40 M) had no signi"cant e!ect on the acidic metabolites of DA.
Time Course of HgCl 2 Ewects on DA, DOPAC, and HVA Levels
In these experiments, rats exposed to 40 M HgCl 1 day after surgery were also exposed to 400 M HgCl 1 week later and 4 mM HgCl 2 weeks later. Figure 3 presents the time course of the e!ects of increased concentrations of HgCl on DA, DOPAC, and HVA striatal levels. The time course was characterized by an initial phase in which DA extracellular levels increased due to the e!ect of 40 M HgCl (Fig. 3A) . This concentration of HgCl did FIG. 3 . Time course of the e!ects of intrastriatal perfusion of increased concentrations of HgCl (rats exposed to 40 M HgCl 1 day after surgery were also exposed to 400 M HgCl 1 week later and 4 mM HgCl 2 weeks later) on DA (A), DOPAC (B), and HVA (C) striatal levels. Arrow denotes the infusion of HgCl over 60 min. The results are presented as means$SEM of four or "ve experiments, expressed as a percentage of the basal levels (100%). Basal levels were considered as the mean of substance concentrations in the three samples before HgCl perfusion. Signi"cant di!erences: *P(0.05, **P(0.01, and ***P(0.001 with respect to basal levels. not a!ect the basal extracellular output of DOPAC or HVA (Figs. 3B and 3C) .
The second phase (1 week after the "rst HgCl infusion) was characterized by an increase in DA levels 90 min after the beginning of 400 M HgCl perfusion (1605$152% increase with respect to basal levels) (Fig. 3A) . In the same period, with the same concentration of 400 M HgCl , DOPAC and HVA levels decreased 44$6% and 39$1%, respectively (Figs. 3B and 3C) .
The third phase (2 weeks after the "rst HgCl infusion) was characterized by a small increase in DA levels 90 min after the beginning of 4 mM HgCl perfusion (613$75% of baseline) (Fig. 3A) , while DOPAC and HVA levels decreased 56$4% and 33$6%, respectively (Figs. 3B and  3C ). The decrease in DOPAC and HVA levels was not signi"cant compared with the decrease observed after the second infusion of HgCl (400 M). Intrastriatal infusion of 400 M and 4 mM HgCl 1 and 2 weeks after the "rst infusion (40 M HgCl ) produced increases in DA levels that were, respectively, 36 and 62% smaller than that observed with the "rst infusion. Moreover, compared with the single administrations of 400 M and 4 mM HgCl (Fig. 2) , the administrations of 400 M and 4 mM HgCl to the same group of rats 1 and 2 weeks after the "rst HgCl infusion (40 M, day 1) indicated that the HgCl e!ects were not only reduced but also delayed by 15 min, especially for the concentration of 4 mM (Fig. 3) , even though increased concentrations of HgCl were used in those experiments.
DISCUSSION
Previous papers reported that di!erent administrations (chronic, acute, and intradialysate) of MeHg induced signi"-cant dose-dependent increases in the striatal DA release (Faro et al., 1997 (Faro et al., , 1998 (Faro et al., , 2000 .
In this study, the administration of all concentrations of HgCl assessed also induced signi"cant increases in DA striatal levels. In contrast with results about DA release after MeHg intrastriatal administration (Faro et al., 2000) , the e!ect of HgCl administration was not dose-dependent: the increases in DA levels induced by HgCl were the same for 400 M and 4 mM HgCl (&2500%). Compairing these results with those obtained with MeHg, the increases in 266 extracellular DA levels induced by HgCl were lower (for the 4 mM concentration) and delayed by 30 min. It is suggested that the e!ect of HgCl reached a maximum with the concentration of 400 M.
The mechanism by which DA levels were increased after intrastriatal administration of HgCl could be due to a direct action of toxicant on dopaminergic neurons at di!erent levels, such as membrane, vesicular release, reuptake system, and transport systems. Previous results suggested that the mechanism that underlies the e!ects of various neurotoxic mercurials (such as Hg> and MeHg) on central synaptic transmission di!er with respect to the sites and potency of action and reversibility (Yuan and Atchison, 1994) .
The extracellular levels of DOPAC and HVA decreased with concentrations of 400 M and 4 mM HgCl , with the decrease of striatal DOPAC being dramatic after the intrastriatal administration of 4 mM HgCl . Since DOPAC is produced intraneuronally from newly synthesized DA (Zetterstrom et al., 1988) , the decreased DOPAC levels observed with the concentration of 4 mM HgCl can be explained as due to a decreased DA synthesis.
The successive administrations (1 and 2 weeks later) of increased concentrations (400 M and 4 mM) of HgCl to the same group of animals that received 40 M HgCl before demonstrated that the e!ect on striatal DA levels was successively lower and delayed compared with the respective e!ects of single administrations: 1605% versus 2583% for the concentration of 400 M and 613% versus 2601% for the concentration of 4 mM. Since the levels of DA metabolites had similar decreases after administration of 400 M and 4 mM HgCl 1 and 2 weeks later, the lower striatal levels can be explained considering that the HgCl a!ects the DA release mechanisms or induces neuronal damage depending on the concentration and time of HgCl administration.
CONCLUSION
The intrastriatal administration of di!erent concentrations of HgCl produced signi"cant increases in the release of DA from rat striatal tissue, which were associated with signi"cant decreases in the extracellular levels of DOPAC and HVA (in the case of the concentrations of 400 M and 4 mM HgCl ). It is suggested that these results may be due to di!erent actions for the di!erent concentrations of HgCl assessed. Thus, lower concentrations of HgCl (400 M) may increase DA release, whereas high concentrations (4 mM) may decrease DA synthesis (even increasing the release of the DA previously synthesized). These results are consistent with other results previously obtained for striatal DA levels (Faro et al., 1997 (Faro et al., , 1998 (Faro et al., , 2000 , enabling us to undertake future studies regarding the e!ects of intrastriatal HgCl administration on the release of other neurotransmitters, such as glutamate and GABA.
